Results 1 to 10 of about 96,622 (267)

Compaction Behavior of Co-Amorphous Systems [PDF]

open access: yesPharmaceutics, 2023
Co-amorphous systems have been shown to be a promising strategy to address the poor water solubility of many drug candidates. However, little is known about the effect of downstream processing-induced stress on these systems.
Cecilie-Mathilde Sørensen   +2 more
doaj   +6 more sources

Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder Blends [PDF]

open access: yesPharmaceutics, 2022
The work evaluates the stability of amorphous and co-amorphous olanzapine (OLZ) in tablets manufactured by direct compression. The flowability and the compressibility of amorphous and co-amorphous OLZ with saccharin (SAC) and the properties of the ...
Nuno F. da Costa   +3 more
doaj   +5 more sources

Co-Amorphous Versus Deep Eutectic Solvents Formulations for Transdermal Administration [PDF]

open access: yesPharmaceutics, 2023
Transdermal administration can be considered as an interesting route to overcome the side-effects inherent to oral intake. Designing topical formulations with maximum drug efficiency requires the optimization of the permeation and the stability of the ...
Yannick Guinet   +2 more
doaj   +6 more sources

Identification of Candesartan Cilexetil-L-Arginine Co-amorphous Formation and Its Solubility Test [PDF]

open access: yesBorneo Journal of Pharmacy, 2022
The formation of co-amorphous is one alternative that can be attempted to enhance the solubility of drugs. The study aimed to identify the co-amorphous formation between candesartan cilexetil (CAN) and l-arginine (ARG) and to know its effect on the ...
Fikri Alatas   +4 more
doaj   +3 more sources

Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone [PDF]

open access: yesPharmaceutics, 2023
Loratadine (LRD), a non-sedating and slow-acting antihistamine, is often given in combination with short-onset chlorpheniramine maleate (CPM) to increase efficacy. However, LRD has poor water solubility resulting in low bioavailability.
Krit Suknuntha   +3 more
doaj   +2 more sources

The Utilisation Of Thermal Methods For The Screening Of Three Component Co-amorphous Systems [PDF]

open access: yesBritish Journal of Pharmacy, 2018
Indomethacin and piroxicam are known to become amorphous upon rapid cooling after melting. Multiple three-component co-amorphous mixtures have been produced via a melt quench method to evaluate the influence of the third component on stability and ...
Alessandra D'Angelo   +2 more
doaj   +3 more sources

Mechanistic Investigation into Crystallization of Hydrated Co-Amorphous Systems of Flurbiprofen and Lidocaine [PDF]

open access: yesPharmaceutics
Background: It is generally accepted that water as a plasticizer can decrease the glass transition temperatures (Tgs) of amorphous drugs and drug delivery systems, resulting in physical instabilities.
Xiaoyue Xu   +4 more
doaj   +2 more sources

Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug–Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug [PDF]

open access: yesPharmaceutics, 2022
Amorphization, typically in the form of amorphous solid dispersion (ASD), represents a well-established solubility enhancement strategy for poorly soluble drugs.
Li Ming Lim, Jin-Won Park, Kunn Hadinoto
doaj   +2 more sources

Sustained Release of Co-Amorphous Matrine-Type Alkaloids and Resveratrol with Anti-COVID-19 Potential [PDF]

open access: yesPharmaceutics, 2022
Matrine (MAR), oxymatrine (OMAR), and sophoridine (SPD) are natural alkaloids with varying biological activities; matrine was recently used for the treatment of coronavirus disease 2019 (COVID-19).
Dandan Hu   +5 more
doaj   +2 more sources

Formation of a Stable Co-Amorphous System for a Brick Dust Molecule by Utilizing Sodium Taurocholate with High Glass Transition Temperature [PDF]

open access: yesPharmaceutics, 2022
Brick dust molecules are usually poorly soluble in water and lipoidal components, making it difficult to formulate them in dosage forms that provide efficient pharmacological effects. A co-amorphous system is an effective strategy to resolve these issues.
Shohei Aikawa   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy